1. Home
  2. KURA vs CHCO Comparison

KURA vs CHCO Comparison

Compare KURA & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • CHCO
  • Stock Information
  • Founded
  • KURA 2014
  • CHCO 1957
  • Country
  • KURA United States
  • CHCO United States
  • Employees
  • KURA N/A
  • CHCO N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • CHCO Major Banks
  • Sector
  • KURA Health Care
  • CHCO Finance
  • Exchange
  • KURA Nasdaq
  • CHCO Nasdaq
  • Market Cap
  • KURA 561.9M
  • CHCO 1.7B
  • IPO Year
  • KURA N/A
  • CHCO N/A
  • Fundamental
  • Price
  • KURA $6.07
  • CHCO $128.88
  • Analyst Decision
  • KURA Strong Buy
  • CHCO Hold
  • Analyst Count
  • KURA 12
  • CHCO 2
  • Target Price
  • KURA $24.50
  • CHCO $127.50
  • AVG Volume (30 Days)
  • KURA 1.3M
  • CHCO 103.1K
  • Earning Date
  • KURA 08-07-2025
  • CHCO 07-22-2025
  • Dividend Yield
  • KURA N/A
  • CHCO 2.45%
  • EPS Growth
  • KURA N/A
  • CHCO 0.39
  • EPS
  • KURA N/A
  • CHCO 7.98
  • Revenue
  • KURA $67,991,000.00
  • CHCO $293,748,000.00
  • Revenue This Year
  • KURA $109.86
  • CHCO $6.69
  • Revenue Next Year
  • KURA $107.90
  • CHCO $1.78
  • P/E Ratio
  • KURA N/A
  • CHCO $16.15
  • Revenue Growth
  • KURA N/A
  • CHCO 1.31
  • 52 Week Low
  • KURA $5.41
  • CHCO $102.22
  • 52 Week High
  • KURA $23.48
  • CHCO $137.28
  • Technical
  • Relative Strength Index (RSI)
  • KURA 45.15
  • CHCO 74.54
  • Support Level
  • KURA $5.58
  • CHCO $121.77
  • Resistance Level
  • KURA $6.00
  • CHCO $121.80
  • Average True Range (ATR)
  • KURA 0.25
  • CHCO 2.47
  • MACD
  • KURA -0.04
  • CHCO 1.14
  • Stochastic Oscillator
  • KURA 26.27
  • CHCO 96.11

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

Share on Social Networks: